Opioid Use Disorder Treatment Expansion and Modernization Act
Formerly H.R.2872, sponsored by Larry Bucshon [R-IN-8] and introduced 6/24/15 with cosponsors Steve Womack [R-AR-3], Steve Chabot [R-OH-1], Steve Stivers [R=OH-15], Daniel Webster [R-FL-10], and Ann Kuster [D-NH-2].
H.R. 4981, sponsored by Larry Bucshon [R-IN-8], was introduced 4/18/16 with cosponsors Paul Tonko [D-NY-20] and Todd Tokita [R-IN-4]. It was referred to the Energy and Commerce and Judiciary Committees. It passed the House on 5/12/16.
Purpose: To amend the Controlled Substances Act to improve access to opioid use disorder treatment.
Finding: that opioid use disorder has become a public health epidemic.
This bill is to increase the numbers of patients that can be treated with opioid antagonist drugs such as Suboxone.
First, it increases the practitioners that can provide such patient care to also include nurse practitioners and physician assistants. Second, it increases the numbers of patients that can be treated from 100 to 250 over a 3 year period, and allows the secretary to even change that number, or exclude patients that receive the drugs directly by the practitioner in the office setting. This could increase the numbers of patients receiving Suboxone astronomically.
It also allows for the “revocation or suspension of registration in case of substantial noncompliance”. But it doesn’t state which registration. It also allows the Secretary to determine the criteria for the revocation/suspension which means they can do whatever they want.
In the report to Congress 2 years later, the Secretary is supposed to include an assessment of compliance and the measures taken by the Secretary to ensure such compliance.